Gainers
Akouos (NASDAQ:AKUS) shares moved upwards by 86.2% to $13.05 during Tuesday's pre-market session. The company's market cap stands at $481.5 million.
AVEO Oncology (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced today that, as disclosed on